Diabetes Core Update cover image

Diabetes Core Update – June 2023

Diabetes Core Update

00:00

Bempedalic Acid and LDL Cholesterol

Ampedalic acid reduced LDL cholesterol, about 21% early on in the trial at about a six month mark. Over the course of the trial, there was a lot of statin and other lipid lowering therapy drop in in the placebo group. But again, at a predisped defined spot of about six months, the change in LDL was about 21.7%.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app